We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-4.46%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$18.3B
AUM Growth
-$3.9B
(-18%)
Cap. Flow
-$2.31B
Cap. Flow
% of AUM
-12.59%
Top 10 Holdings %
Top 10 Hldgs %
30.49%
Holding
560
New
66
Increased
141
Reduced
222
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$317M |
| 2 |
Yum! Brands
YUM
|
+$222M |
| 3 |
CELG
Celgene Corp
CELG
|
+$213M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$211M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$194M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$264M |
| 2 |
Blackstone
BX
|
+$256M |
| 3 |
Cigna
CI
|
+$232M |
| 4 |
Hartford Financial Services
HIG
|
+$206M |
| 5 |
CVS Health
CVS
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.98% |
| 2 | Technology | 17.05% |
| 3 | Consumer Discretionary | 15.78% |
| 4 | Communication Services | 12.84% |
| 5 | Financials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
TSMC
TSM
$2.09T
| $545K | ﹤0.01% |
+26,275
| New | +$552K |
|
427
Vipshop
VIPS
$6.84B
| $537K | ﹤0.01% |
31,947
+18,035
| +130% | +$346K |
|
428
Vericel Corp
VCEL
$2.3B
| $531K | ﹤0.01% |
196,093
| – | – |
|
|
RDHL
429
Redhill Biopharma
RDHL
$3.85M
| $529K | ﹤0.01% |
41
+6
| +17% | +$88.8K |
|
|
ADVM
430
DELISTED
Adverum Biotechnologies
ADVM
| $527K | ﹤0.01% |
6,395
+4,450
| +229% | +$569K |
|
431
Glaukos
GKOS
$9.02B
| $509K | ﹤0.01% |
21,050
-87,185
| -81% | -$2.62M |
|
432
Clean Harbors
CLH
$16.1B
| $508K | ﹤0.01% |
11,545
| – | – |
|
|
FWP
433
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $508K | ﹤0.01% |
+3,079
| New | +$647K |
|
|
MDCO
434
DELISTED
Medicines Co
MDCO
| $499K | ﹤0.01% |
+13,150
| New | +$462K |
|
|
ADAP
435
DELISTED
Adaptimmune Therapeutics
ADAP
| $497K | ﹤0.01% |
41,545
+13,100
| +46% | +$185K |
|
436
Ocular Therapeutix
OCUL
$1.86B
| $496K | ﹤0.01% |
35,307
| – | – |
|
437
Compañía de Cervecerías Unidas
CCU
$2.12B
| $487K | ﹤0.01% |
22,000
+7,000
| +47% | +$154K |
|
|
ARIA
438
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $483K | ﹤0.01% |
+82,650
| New | +$637K |
|
439
Itron
ITRI
$3.73B
| $480K | ﹤0.01% |
15,035
| – | – |
|
440
Aecom
ACM
$9.07B
| $479K | ﹤0.01% |
17,395
| – | – |
|
|
ONCE
441
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $453K | ﹤0.01% |
10,850
-2,000
| -16% | -$104K |
|
|
OTIC
442
DELISTED
Otonomy, Inc.
OTIC
| $420K | ﹤0.01% |
23,600
| – | – |
|
|
AMED
443
DELISTED
Amedisys
AMED
| $414K | ﹤0.01% |
+10,900
| New | +$460K |
|
444
Natera
NTRA
$37.5B
| $410K | ﹤0.01% |
+37,800
| New | +$641K |
|
|
EMC
445
DELISTED
EMC CORPORATION
EMC
| $409K | ﹤0.01% |
16,925
-98
| -0.6% | -$2.48K |
|
|
ZSPH
446
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $384K | ﹤0.01% |
+5,850
| New | +$351K |
|
447
Globant
GLOB
$1.35B
| $374K | ﹤0.01% |
+12,210
| New | +$376K |
|
448
Lindsay Corp
LNN
$1.16B
| $374K | ﹤0.01% |
5,510
| – | – |
|
449
NiSource
NI
$22.4B
| $371K | ﹤0.01% |
+20,000
| New | +$342K |
|
|
IMOS
450
ChipMOS TECHNOLOGIES
IMOS
$1.92B
| $362K | ﹤0.01% |
20,020
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q3 2015 Portfolio in Review
As of Q3 2015, Fred Alger Management held 560 positions worth $18.3B, down 18% from $22.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fred Alger Management withdrew a net $2.31B in Q3 2015, closing 94 positions and reducing 222 holdings. Its most notable exit was Oracle, an estimated $104M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Amgen worth $114M.
- Fred Alger Management's largest Q3 2015 buy was Amgen: 823,462 shares worth $114M.
- Fred Alger Management added most to Microsoft in Q3 2015, an estimated $317M increase.
- Fred Alger Management's biggest Q3 2015 reduction was Meta Platforms (Facebook), cutting an estimated $264M.
- Fred Alger Management fully exited Oracle in Q3 2015, selling an estimated $104M.
- Fred Alger Management's ten largest holdings make up 30% of its $18.3B portfolio in Q3 2015.
- Fred Alger Management opened 66 new positions and closed 94 in Q3 2015.
- Fred Alger Management's portfolio value fell 18% quarter-over-quarter to $18.3B.
Based on Fred Alger Management's 13F filing for Q3 2015, filed 16 Nov 2015.